Skip to main content
Top
Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2024

Open Access 01-12-2024 | Cerebral Small Vessel Disease | Research

Whole exome sequencing in a sample of Egyptian patients with covert cerebral small vessel disease

Authors: Hany Aref, Mohamed Maged, Tamer Roushdy, Hossam Shokri, Eman Hamid, Bernard P. H. Cho, Hugh S. Markus, Mai Fathy, Nevine El Nahas

Published in: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery | Issue 1/2024

Login to get access

Abstract

Background

Covert cerebral small vessel disease (cCSVD) is associated with many age-related morbidities with little available data regarding the pathophysiology and role of genetics in it. This study aims to investigate the genetic load in a sample of Egyptian patients with cCSVD.

Results

Thirty patients with cCSVD were recruited and underwent cognitive, gait, sphincter assessment, magnetic resonance imaging (MRI) brain, and blood sampling for whole exome sequencing. The mean age for the patients was 65.93 ± 8.8 with male patients representing 63.33% of the studied sample. The major risk factor was hypertension followed by diabetes mellitus, dyslipidaemia, and smoking. The main presenting symptom was cognitive impairment, found in 60% of the patients and the mean duration of symptoms was 2.1 ± 1.12 years. Two out of thirty patients were positive for a known pathogenic gene (NOTCH3 and COL4A1) despite the absence of family history in one representing 6.7% of the entire studied sample. Meanwhile, three patients had variant genes not previously linked to cCSVD.

Conclusions

Whole exome sequencing and genetic studying of patients with cCSVD is of utmost importance as the genetic load is underestimated in the Egyptian population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.CrossRefPubMed Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701.CrossRefPubMed
2.
go back to reference Ilinca A, Samuelsson S, Piccinelli P, Soller M, Kristoffersson U, Lindgren AG. A stroke gene panel for whole-exome sequencing. Eur J Hum Genet. 2019;27(2):317–24.CrossRefPubMed Ilinca A, Samuelsson S, Piccinelli P, Soller M, Kristoffersson U, Lindgren AG. A stroke gene panel for whole-exome sequencing. Eur J Hum Genet. 2019;27(2):317–24.CrossRefPubMed
3.
go back to reference Bohlega S, Al Shubili A, Edris A, Alreshaid A, Alkhairallah T, AlSous MW, et al. CADASIL in Arabs: clinical and genetic findings. BMC Med Genet. 2007;9(8):67.CrossRef Bohlega S, Al Shubili A, Edris A, Alreshaid A, Alkhairallah T, AlSous MW, et al. CADASIL in Arabs: clinical and genetic findings. BMC Med Genet. 2007;9(8):67.CrossRef
4.
go back to reference Oluwole OJ, Ibrahim H, Garozzo D, Ben Hamouda K, Ismail Mostafa Hassan S, Hegazy AM, et al. Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man. Neurol Genet. 2019;6(1): e382.CrossRefPubMedPubMedCentral Oluwole OJ, Ibrahim H, Garozzo D, Ben Hamouda K, Ismail Mostafa Hassan S, Hegazy AM, et al. Cerebral small vessel disease due to a unique heterozygous HTRA1 mutation in an African man. Neurol Genet. 2019;6(1): e382.CrossRefPubMedPubMedCentral
5.
go back to reference Rahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009;9(1):54–61.CrossRefPubMed Rahman TT, El Gaafary MM. Montreal Cognitive Assessment Arabic version: reliability and validity prevalence of mild cognitive impairment among elderly attending geriatric clubs in Cairo. Geriatr Gerontol Int. 2009;9(1):54–61.CrossRefPubMed
6.
go back to reference Wolf SL, Catlin PA, Gage K, Gurucharri K, Robertson R, Stephen K. Establishing the reliability and validity of measurements of walking time using the emory functional ambulation profile. Phys Ther. 1999;79(12):1122–33.CrossRefPubMed Wolf SL, Catlin PA, Gage K, Gurucharri K, Robertson R, Stephen K. Establishing the reliability and validity of measurements of walking time using the emory functional ambulation profile. Phys Ther. 1999;79(12):1122–33.CrossRefPubMed
7.
go back to reference Berg K. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can. 1989;41(6):304–11.CrossRef Berg K. Measuring balance in the elderly: preliminary development of an instrument. Physiother Can. 1989;41(6):304–11.CrossRef
8.
go back to reference Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683–9.CrossRefPubMed Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43(9):1683–9.CrossRefPubMed
9.
go back to reference Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–34.CrossRefPubMedPubMedCentral Staals J, Makin SD, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228–34.CrossRefPubMedPubMedCentral
10.
go back to reference Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72.CrossRefPubMed Pasquier F, Leys D, Weerts JG, Mounier-Vehier F, Barkhof F, Scheltens P. Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol. 1996;36(5):268–72.CrossRefPubMed
11.
go back to reference Farag S, Kenawy FF, Shokri HM, Zakaria M, Aref H, Fahmi N, et al. The clinical characteristics of patients with pre-existing leukoaraiosis compared to those without leukoaraiosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2021;30(9): 105956.CrossRefPubMed Farag S, Kenawy FF, Shokri HM, Zakaria M, Aref H, Fahmi N, et al. The clinical characteristics of patients with pre-existing leukoaraiosis compared to those without leukoaraiosis in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2021;30(9): 105956.CrossRefPubMed
12.
go back to reference Tong Y, Xu Y, Scearce-Levie K, Ptácek LJ, Fu YH. COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo. Neurogenetics. 2010;11(1):41–52.CrossRefPubMed Tong Y, Xu Y, Scearce-Levie K, Ptácek LJ, Fu YH. COL25A1 triggers and promotes Alzheimer’s disease-like pathology in vivo. Neurogenetics. 2010;11(1):41–52.CrossRefPubMed
13.
go back to reference Manini A, Pantoni L. Genetic causes of cerebral small vessel diseases. Neurology. 2023;100(16):766–83.CrossRefPubMed Manini A, Pantoni L. Genetic causes of cerebral small vessel diseases. Neurology. 2023;100(16):766–83.CrossRefPubMed
14.
go back to reference Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.CrossRefPubMed Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18(7):684–96.CrossRefPubMed
15.
go back to reference Haffner C, Malik R, Dichgans M. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab. 2016;36(1):158–71.CrossRefPubMedPubMedCentral Haffner C, Malik R, Dichgans M. Genetic factors in cerebral small vessel disease and their impact on stroke and dementia. J Cereb Blood Flow Metab. 2016;36(1):158–71.CrossRefPubMedPubMedCentral
16.
go back to reference Ferguson AC, Thrippleton S, Henshall D, et al. Frequency and phenotype associations of rare variants in 5 monogenic cerebral small vessel disease genes in 200,000 UK Biobank participants. Neurol Genet. 2022;8(5): e200015.CrossRefPubMedPubMedCentral Ferguson AC, Thrippleton S, Henshall D, et al. Frequency and phenotype associations of rare variants in 5 monogenic cerebral small vessel disease genes in 200,000 UK Biobank participants. Neurol Genet. 2022;8(5): e200015.CrossRefPubMedPubMedCentral
17.
go back to reference Wanner C, Germain DP, Hilz MJ, Spada M, Falissard B, Elliott PM. Therapeutic goals in Fabry disease: recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy. Mol Genet Metab. 2019;126(3):210–1.CrossRefPubMed Wanner C, Germain DP, Hilz MJ, Spada M, Falissard B, Elliott PM. Therapeutic goals in Fabry disease: recommendations of a European expert panel, based on current clinical evidence with enzyme replacement therapy. Mol Genet Metab. 2019;126(3):210–1.CrossRefPubMed
Metadata
Title
Whole exome sequencing in a sample of Egyptian patients with covert cerebral small vessel disease
Authors
Hany Aref
Mohamed Maged
Tamer Roushdy
Hossam Shokri
Eman Hamid
Bernard P. H. Cho
Hugh S. Markus
Mai Fathy
Nevine El Nahas
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
DOI
https://doi.org/10.1186/s41983-024-00810-2

Other articles of this Issue 1/2024

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 1/2024 Go to the issue